UnclearFiled 14 July 2026
FORE US Bio Inc. has sold $70.4M so far
FORE US Bio Inc., a biotech company based in Philadelphia, PA, has sold $70.4M so far in its equity round, according to a filing dated 14 July 2026.
The announcement check found a page that may be about this round, and could not tell for sure. fore.bio ↗
- Filed
- 14 July 2026
- First filed
- 15 May 2025
- Round
- Equity round (amended filing)
- Amount sold
- $70.4M
- Offering size
- $110M
- Investors so far
- 20
- Based in
- Philadelphia, PA
- Website
- fore.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 88% of the 854 tracked raises with an amount filed in 2026, and than 87% of the 79 in biotech.
FORE US Bio Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 14 Jul 2026 | Amended filing | $70.4M | This raise |
More with SR One Capital on the board
- Avenzo Therapeutics, Inc.$47.2M
- Rezo Therapeutics, Inc.$68.1M
- ADARx Pharmaceuticals, Inc.$200M
- Dren Bio, Inc.$62.5M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.